Family Medicine Doctors in Waco, TX Accepting Medicare

207 Family Medicine doctors found. Showing 201 - 207

Dr. Carlos Arnoldo Guerra, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2201 Macarthur, Waco, TX 76708 Phone: 254-202-6000    Fax: 254-202-6005

Daniel Payne, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 801-783-0566

Abdur Rehman Aqeel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000    Fax: 254-202-5651

Sharon Reece, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7700 Fish Pond Rd, Waco, TX 76710 Phone: 254-724-2111

Dr. John Daly Dietrick, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200    Fax: 254-313-4531

Rachel Rube, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200    Fax: 254-313-4531

Abigail Amanda Latsa, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4400    Fax: 254-313-4549

News Archive

Asthma is the most common underlying condition associated with H1N1 Swine Flu: CDC Report

Cannabis Science Inc., an emerging pharmaceutical cannabis company, notes a report by epidemiologists at the Centers for Disease Control and Prevention (CDC) saying that, among people hospitalized with severe cases of the pandemic strain of H1N1 Swine Flu, asthma is by far the most common underlying condition associated with he disease.

Neoprobe, Devicor sign gamma detection device asset purchase agreement

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.

Antibiotic combined with measurement technology may save time and money in developing new active ingredients

A minimal – and therefore innocuous – dose of an antibiotic coupled with highly sensitive measurement technology could save time and money in the development of new active ingredients.

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, announced that preclinical results for CYT997 were presented today in a poster by Cytopia Limited at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, Massachusetts.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11(current)